Skip to main content
OpenTrials
Completed

NCT Number: NCT06674174

Effect of Lower Limb Resistance Versus Endurance Training in Smokers

Patients was selected based on inclusion and exclusion criteria. Experimental group was treated with Resistance training while control group received endurance training. Data was collected by spirometry and International Physical activity questionnaire readings was recorded in every session for baseline, 3rd week and 6thweeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

25 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Samina International Hospital

Dera Ismāīl Khān, Pakistan

About this study

Experimental group will receive lower limb strength training and control group will receive endurance training. Both groups will receive treatment for three days a week and each session will be given according to FITT formula. Measurement will be recorder pre-treatment and post treatment of both groups at baseline, third , and 6 th week.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Young cigarette smokers (10 cigarette/day for at least 10 years)
  • Male
  • Age 25-45 years
  • Sedentary lifestyle
  • Body mass: less than 80kg
  • BMI:22-30

Exclusion criteria

  • Heart or pulmonary disease
  • MSK disorder
  • incapable of realizing the protocol of exercises,
  • Recent surgery
  • Recent Trauma.
  • Any infective respiratory illness.

Treatment and study plan

lower limb strength training

Other

Experimental group will receive lower limb strength training treatment for three days a week and each session will last for an hour for 3 consecutivemonths. Measurement will be recorder pre-treatment and post treatment of both groupsat baseline,3rd, and 6th week.

Endurance training

Other

Control group will receive endurance training, treatment for three days a week and each session will last for an hour for 3 consecutivemonths. Measurement will be recorder pre-treatment and post treatment of both groupsat baseline,3rd, and 6th week.

Primary outcomes

  1. Spirometry

    Time frame: 6 weeks

    Spirometry is one of the Pulmonary Function Test; they are useful investigations in the management of patients with respiratory disease or respiratory weakness secondary to neurological impairment. They aid diagnosis, help monitor response to treatment and can guide decisions regarding further treatment and intervention. Spirometry can measure all the lung volumes except residual volume.

  2. International Physical Activity Questionnaire

    Time frame: 6 weeks

    The International Physical Activity Questionnaire is a 27-item self-reported measure of physical activity for use with individual adult patients aged 15 to 69 years old. The International Physical Activity Questionnaire can be used clinically and in population research that compares physical activity levels between populations internationally.To calculate MET minutes a week multiply the MET value given (remember walking = 3.3, moderate activity = 4, vigorous activity = 8) by the minutes the activity was carried out and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET minutes for that activity are 3.3 X 30 X 5=495 Met minutes a week.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Lower Limb Resistance Versus Endurance Training on Pulmonary Function in Smokers With Shortness of Breath

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 5, 2024
Registry last updated
Nov 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.